A lawsuit was filed on behalf of investors in NASDAQ:HZNP shares over alleged securities laws violations and NASDAQ:HZNP investors should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 03/28/2016 --A shareholder of Horizon Pharma Inc (NASDAQ:HZNP) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Horizon Pharma Inc in connection with certain allegedly false and misleading statements.

Investors who purchased a significant amount of shares of Horizon Pharma Inc (NASDAQ:HZNP) between March 13, 2014 and February 26, 2016, have certain options and for certain investors are short and strict deadlines running. Deadline: May 9, 2016. NASDAQ:HZNP investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The plaintiff alleges on behalf of purchasers of Horizon Pharma Inc (NASDAQ:HZNP) common shares between March 13, 2014 and February 26, 2016, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between March 13, 2014 and February 26, 2016 Defendants made allegedly false and/or misleading statements and/or allegedly failed to disclose that Horizon's Prescriptions Made Easy ("PME") program was designed to artificially inflate the prices of minor differentiation standard retail drugs, that sales revenues from drugs sold through Horizon's PME program were unsustainable at these inflated price levels, that Horizon's use of its PME program left the Company subject to increased regulatory risks, that Horizon received a subpoena from the Office of the U.S. Attorney for the Southern District of New York in November 2015, and that as a result of the foregoing, Defendants' statements about Horizon's business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

On February 29, 2016, Horizon Pharma Inc disclosed in its 2015 annual report that the Company received a subpoena in November 2015 from the Office of the U.S. Attorney for the Southern District of New York for documents and information related to the Company's patient assistance programs, which include providing free medicines and copay coupons to help cover out-of-pocket drug costs, and other aspects of Horizon's sales and marketing activities.

Those who purchased shares of Horizon Pharma Inc (NASDAQ:HZNP) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com